An Evaluation of the WHO QUAlityRights Program
Launched by GCS-CCOMS · Mar 7, 2025
Trial Information
Current as of April 22, 2025
Active, not recruiting
Keywords
ClinConnect Summary
In France, despite the existence of recommendations and a restrictive legal framework, the use of restraint practices in psychiatry remains widespread, and the duration and conditions of hospitalization do not always guarantee respect for users' rights.
The World Health Organization's (WHO) QualityRights (QR) program offers assessments, called "observations", and recommendations to help mental health facilities, on a voluntary basis, improve their care practices towards better respect of the rights of service users. However, the program has never been evaluated in a French national context...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (18 years or older)
- • Persons having formulated a non-opposition to participate in the study
- • Population a (users): Service users of the psychiatric sectors involved in the study hospitalized full-time since at least 3 days in an inpatient unit.
- • Population b (professionals): Mental health professionals working in the sector since at least 3 months at the time of study participation
- Exclusion Criteria:
- • Persons physically or psychologically unable to participate at the time of the study
- • Persons subject to a safeguard of justice measure
- • Persons who do not speak or understand the French language
Trial Officials
Déborah Sebbane, MD, PhD
Study Chair
GCS-CCOMS & ECEVE 1123 INSERM
About Gcs Ccoms
GCS-CCOMS is a leading clinical trial sponsor dedicated to advancing innovative therapies through rigorous research and development. With a strong commitment to enhancing patient outcomes, the organization specializes in the design, implementation, and management of clinical trials across various therapeutic areas. GCS-CCOMS collaborates with academic institutions, healthcare providers, and pharmaceutical companies to ensure the highest standards of scientific integrity and regulatory compliance. Through a patient-centered approach and a focus on ethical practices, GCS-CCOMS strives to contribute to the advancement of medical knowledge and improve the quality of care available to patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Armentières, , France
Armentières, , France
Erstein, , France
Laxou, , France
Montéléger, , France
Nanterre, , France
Nice, , France
Plaisir, , France
Plaisir, , France
Pont Du Casse, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported